Role of Arterial Spin Labelling Magnetic Resonance Prefusion in Grading of Pediatric Brain Tumors

ConditionPediatric Brain Tumors

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age0-18

SponsorAssiut University

About this trial

To evaluate the diagnostic performance of arterial spin labelling (ASL) magnetic resonance perfusion in preoperative grading of pediatric brain tumors.

Eligibility criteria

Qualifiers

Pediatric patients aged 18 years or younger.

Patients with radiological diagnosis of intracranial brain tumors.

Disqualifiers

Patients who have received prior surgery, chemotherapy or radiotherapy for brain tumors.

Patients with contraindications to magnetic resonance imaging (MRI) examination.

Trial design

Treatments tested in this trial

Not listed

Trial groups

20 Participants

are grouped into 2 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov